Efficacy and Safety of Tapentadol ER for Diabetic Peripheral Neuropathic Pain: Results of a Randomized-Withdrawal, Double-Blind, Placebo-Controlled Phase III Study

被引：0
|
作者：
Etropolski, Mila
Shapiro, Douglas
Okamoto, Akiko
Rauschkolb-Loeffler, Christine
Haeussler, Juergen
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A217 / A218
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Busse, W. W.
    Wenzel, S. E.
    Meltzer, E. O.
    Kerwin, E. M.
    Liu, M. C.
    Zhang, N.
    Chon, Y.
    Lin, J.
    Lin, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
  • [22] Efficacy and Safety of LX9211 for Relief of Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1): Results of a Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study
    Pop-Busui, Rodica
    Patel, Anand
    Sang, Christine Nai-Mei
    Banks, Phillip L.
    Pierce, Phillip F.
    Sun, Franklin
    Granowitz, Craig
    Gopinathan, Suma
    DIABETES CARE, 2024, 47 (08)
  • [23] A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled 14-Week Study of Mirogabalin in Chinese Patients with Diabetic Peripheral Neuropathic Pain
    Guo, Xiaohui
    Yu, Yang
    Zhang, Yongbo
    Sun, Li
    Li, Yufeng
    Song, Bing
    Hang, Li
    Baba, Masayuki
    Wasaki, Yosuke
    Kikumori, Kunika
    Murayama, Emiko
    PAIN AND THERAPY, 2024, 13 (04) : 937 - 952
  • [24] The safety and efficacy of Omalizumab in chronic idiopathic/dpontaneous urticaria: Results from a phase iii randomized, double-blind, placebo-controlled study
    Katelaris, C. H.
    Maurer, M.
    Staubach, P.
    Ashby, M.
    Canvin, J.
    Ledford, D.
    Kaplan, A.
    Jakob, T.
    Rosen, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 37 - 37
  • [25] Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study
    Kerscher, Martina
    Rzany, Berthold
    Prager, Welf
    Turnbull, Catriona
    Trevidic, Patrick
    Inglefield, Christopher
    DERMATOLOGIC SURGERY, 2015, 41 (10) : 1149 - 1157
  • [26] An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain
    Toth, Cory
    Mawani, Shefina
    Brady, Shauna
    Chan, Cynthia
    Liu, CaiXia
    Mehina, Essie
    Garven, Alexandra
    Bestard, Jennifer
    Korngut, Lawrence
    PAIN, 2012, 153 (10) : 2073 - 2082
  • [27] OBSTRUCTIVE SLEEP APNEA: EFFICACY AND SAFETY RESULTS OF A 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL TRIAL OF SOLRIAMFETOL (JZP-110)
    Strollo, P. J.
    Redline, S.
    Hedner, J.
    Collop, N.
    Chen, D.
    Li, J.
    Carter, L. P.
    Lee, L.
    Black, J.
    Pepin, J. -L.
    SLEEP MEDICINE, 2017, 40 : E316 - E316
  • [28] Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
    Buynak, Robert
    Shapiro, Douglas Y.
    Okamoto, Akiko
    Van Hove, Ilse
    Rauschkolb, Christine
    Steup, Achim
    Lange, Bernd
    Lange, Claudia
    Etropolski, Mila
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (11) : 1787 - 1804
  • [29] NABUMETONE IN POSTOPERATIVE PAIN - RESULTS OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
    PELLERIN, I
    RESTELLI, L
    VAIANI, G
    NATALE, C
    MOVILIA, PG
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 170 - 170
  • [30] Transdermal buprenorphine in the treatment of chronic pain: Results of a Phase III, multicenter, randomized, double-blind, placebo-controlled study
    Sorge, J
    Sittl, R
    CLINICAL THERAPEUTICS, 2004, 26 (11) : 1808 - 1820
12345